In the last trading session, 1.01 million shares of the Adaptive Biotechnologies Corp (NASDAQ:ADPT) were traded, and its beta was 1.76. Most recently the company’s share price was $8.93, and it changed around $0.09 or 1.02% from the last close, which brings the market valuation of the company to $1.36B. ADPT currently trades at a discount to its 52-week high of $10.28, offering almost -15.12% off that amount. The share price’s 52-week low was $2.99, which indicates that the current value has risen by an impressive 66.52% since then.
Adaptive Biotechnologies Corp stock received a consensus recommendation rating of Overweight, based on a mean score of 1.25. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 1 recommended ADPT as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight.
Adaptive Biotechnologies Corp (NASDAQ:ADPT) trade information
Instantly ADPT has showed a green trend with a performance of 1.02% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 9.43 on recent trading dayincreased the stock’s daily price by 5.3%. The company’s shares are currently up 48.96% year-to-date, but still down -1.33% over the last five days. On the other hand, Adaptive Biotechnologies Corp (NASDAQ:ADPT) is 13.18% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $14, which translates to bulls needing to increase their stock price by 36.21% from its current value. Analyst projections state that ADPT is forecast to be at a low of $5 and a high of $18.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -1.51%. Adaptive Biotechnologies Corp earnings are expected to increase by 22.63% in 2025, but the outlook is positive 29.40% per year for the next five years.
ADPT Dividends
Adaptive Biotechnologies Corp’s next quarterly earnings report is expected to be released in June.
RUBRIC CAPITAL MANAGEMENT LP, with 9.4971% or 14.0 million shares worth $50.68 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
ARK ETF Trust-ARK Genomic Revolution ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Apr 30, 2025 . The former held 5.96 shares worth $53.19 million, making up 3.92% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 4.2 shares worth around $37.49 million, which represents about 2.76% of the total shares outstanding.
